Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07215611
Status
Recruiting
Apply to this trial

Conditions

  • Bone Sarcomas
  • Financial Toxicity

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • data collection — OTHER
    data collection from electronic health records

Study Details

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Key Dates

Start date
Sep 2, 2025
Status verified
Apr 2026
Primary completion
Oct 2, 2028
Completion
Oct 2, 2030

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Questionnaires [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Shalin S Patel, MD
[email protected]
713-792-6268
Shalin S Patel, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies